Literature DB >> 14426934

Protection against acute trauma and traumatic shock by vasodilators.

M NICKERSON, S A CARTER.   

Abstract

Entities:  

Keywords:  HYDRALAZINE/pharmacology; SHOCK/experimental; SYMPATHOLYTICS/pharmacology

Mesh：

Substances：

Year:  1959        PMID： 14426934

Source DB:  PubMed          Journal:  Can J Biochem Physiol


× No keyword cloud information.
  10 in total

1.  THE INFLUENCE OF RESERPINE PRETREATMENT UPON THE HEMODYNAMICS OF DOGS DURING HEMORRHAGIC HYPOTENSION.

Authors:  E SEIFEN; W FLACKE; M H ALPER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-04-21

2.  [THE BEHAVIOR OF CATECHOLAMINES IN OPERATIONS USING EXTRACORPOREAL CIRCULATION].

Authors:  A STURM
Journal:  Klin Wochenschr       Date:  1963-10-15

3.  CLINICAL, BIOCHEMICAL, AND HAEMODYNAMIC STUDIES IN MAN DURING REFRACTORY HYPOTENSION.

Authors:  L C JENKINS; W A DODDS; H B GRAVES
Journal:  Can Anaesth Soc J       Date:  1965-01

4.  THE TREATMENT OF SUPERIOR MESENTERIC ARTERY OCCLUSION: A REAPPRAISAL.

Authors:  A A KLASS
Journal:  Can Med Assoc J       Date:  1965-08-14       Impact factor: 8.262

5.  Anaesthetic management of severe injuries.

Authors:  R G GILBERT
Journal:  Can Anaesth Soc J       Date:  1963-01

6.  Vascular adjustments during the development of shock.

Authors:  M Nickerson
Journal:  Can Med Assoc J       Date:  1970-10-17       Impact factor: 8.262

7.  Combined adrenergic blockade in experimental hemorrhagic hypotension.

Authors:  G Zierott; E Pappova; P Lundsgaard-Hansen
Journal:  Pflugers Arch       Date:  1969-06-24       Impact factor: 3.657

8.  Refractory shock.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1966-04       Impact factor: 1.967

9.  Experimental pneumococcal and staphylococcal sepsis: effects of hydrocortisone and phenoxybenzamine upon mortality rates.

Authors:  H G Robson; L E Cluff
Journal:  J Clin Invest       Date:  1966-09       Impact factor: 14.808

10.  Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation.

Authors:  Suresh K Kesavan; Shweta Bhat; Sandeep B Golegaonkar; Mashanipalya G Jagadeeshaprasad; Arati B Deshmukh; Harshal S Patil; Santosh D Bhosale; Mahemud L Shaikh; Hirekodathakallu V Thulasiram; Ramanamurthy Boppana; Mahesh J Kulkarni
Journal:  Sci Rep       Date:  2013-10-15       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.